BRIEF-Genmab says U.S. FDA grants priority review for daratumumab in relapsed multiple myeloma
October 07, 2016 at 19:16 PM EDT
* u.s. Fda grants priority review for daratumumab in relapsed multiple myeloma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.